天天彩票投注


EPOSINO
No.1 export brand of EPO in China

As the first genetically engineered drug in China, EPOSINO is produced strictly complying with European standards. The product has been exported to more than 30 countries and regions, making it the EPO product with the largest export in China. In October 2011, the new indications 10000IU/ml EPO was brought into the market, only three companies in China produced this indication.

 

In 2002, EPOSINO was awarded as China High-quality Product certificate by French Science and Technology Quality Supervision and Evaluation Committee, and recognized as recommended products in EU market by China Council for the Promotion of International Trade and the French Science and Technology Quality Supervision and Evaluation Committee.

 

Core product advantages

Reach EU standard, ranked 1st in Export

Exclusive formula free of human serum albumin to avoid the risk of virus transmission for safer use.

The use of phosphate buffer to reduce the pain of injection, and improve patient feeling and acceptance of medication

Quality strictly complies with EU standards

Created seven No.1s in China

In 1992, the first to introduce the product in China.

In 1996, the first batch to receive New Biological Product certificate from the Ministry of Health in China.

In 1998, the first to get the State Food and Drug Administration approved and registered by EPO

In 1999, won Top Ten Tigh-tech Projects, and First Prize in Pharmaceutical Technology Progress in Shandong Province.

In 2000, the first pre-filled package was introduced in China.

In 2004, the exclusive decelopment of the domestic EPO3000IU does not contain Human Albumin prefikked syringe packaging ,the national inventionpatent

Since 2005, the products have been registered in more than 20 countries and ranked first in export in China.

 

Product Manual

download

Please read the instructions carefully and use them under the guidance of a physician

[NAME]

Genetic Name:Recombinant Human Erythropoietin Injection (CHO cell)

Brand Name:EPOSINO

 

[INDICATIONS]

Patients who have anemia caused by renal insufficiency, with or without hemodialysis.

Red cell mobilization in perioperative period.

 

[SPECIFICATION]

Penicillin bottle:2000IU/ml/vial;3000IU/ml/vial.

Prefilled syringes: 2000IU/1ml/vial;2000IU/0.5ml/vial:3000IU/1ml/vial;4000IU/1ml/vial;4000IU/0.5ml/vial;6000IU/1ml/vial; 6000IU/0.5ml/vial;10000IU/1ml/vial;10000IU/0.5ml/vial

 

[ADMINISTRATION AND DOSAGE]

1.Renal anemia

Use it under the guidance of doctors. Use hypodermic injection or intravenous injection for 2~3 times per week. The dosage should be adjusted according to the degree of anemia, age and other relevant factors.

Treatment period: The recommend dose at the beginning for hemodialysis patients is 100~150IU/kg per week, and for patients without hemodialysis is 75~100IU/kg per week. If the increase of hematokrit is less than 0.5vol% per week, can increase the dose to 15~30IU/kg after 4 weeks, but not more than 30IU/kg per week. The hematokrit should increase to 30~33vol% but should not more than 36vol%.

Maintenance period: If the hematokrit reaches 30~33vol% or/and hemoglobin reaches 100~110g/L, then the treatment is into maintenance period. Recommend to adjust the dose to 2/3 of the amount in the treatment period and check hematokrit every 2~4 weeks to adjust the dose for preventing the overspeed of erythropoiesis and maintaining the hematokrit and hemoglobin in a appropriate level.

2.Red cell mobilization in perioperative period

Indicated for the patients undergoing elective surgery (cardiac surgery is excepted) and his/her hemoglobin is 100-130g/L, the dose is 150IU/kg body weight, 3 times per week, hypodermic injection, use it from 10 days before surgery to 4 days after surgery, can relief the anemia during and after the surgery, reduce the requirement of allogeneic blood transfusion, speed up the recovery of anemia after surgery. During the use of this medicine, iron supplementation is needed for preventing iron deficiency.

 

[CONTRAINDICATIONS]

1.Uncontrolled severe hypertension patients.

2.Co-infected patients should control the infection before use this medicine.

 

[STORAGE]

2-8℃, keep in dark for storage and transportation

 

[MANUFACUTURER]

Company Name:Shandong Kexing Bioproducts Co.,Ltd.

Production Address:No.2666, Chuangye Road, Mingshui Development Zone, Zhangqiu, Shandong, China

Zip Cod:250200

Telephone:(0531)83326820;800-8304545

Fax:0755-26632044

Website:

International Business

Continue to understand >